Itafos (TSE:IFOS)
:IFOS
Top Page
Itafos
(IFOS)
Select Model
Select Model
Rating:70Outperform
Price Target:
C$4.00
▲(31.15% Upside)
Action:ReiteratedDate:03/21/26
The score is driven primarily by strong valuation (very low P/E and high dividend yield) balanced against financial-performance risk from weak cash flow conversion and cyclical earnings history. Technical indicators are neutral-to-modestly positive and provide limited additional support.
Positive Factors
Balance sheet health
A repaired balance sheet with low debt-to-equity and a stronger equity base materially reduces refinancing and liquidity risk over the medium term. This durability supports sustained capital allocation for maintenance capex, potential dividends, and cushions cycles in commodity demand.
Negative Factors
Weak cash flow conversion
Material gap between accounting earnings and cash conversion limits the firm's ability to self-fund growth, capex, and shareholder returns. Persistent weak free cash flow increases reliance on external financing and magnifies vulnerability to commodity-price and working-capital swings.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet health
A repaired balance sheet with low debt-to-equity and a stronger equity base materially reduces refinancing and liquidity risk over the medium term. This durability supports sustained capital allocation for maintenance capex, potential dividends, and cushions cycles in commodity demand.
Read all positive factors
Itafos (IFOS) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$730.26M
Dividend YieldN/A
Average Volume (3M)69.51K
Price to Earnings (P/E)3.5
Beta (1Y)0.24
Revenue Growth20.52%
EPS Growth1196.33%
CountryCA
Employees437
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)0.26
Shares Outstanding194,217,990
10 Day Avg. Volume75,524
30 Day Avg. Volume69,511
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.95
Price to Sales (P/S)0.73
P/FCF Ratio87.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.37
Revenue Forecast (FY)C$577.33M
Itafos Business Overview & Revenue Model
Company Description
Itafos (IFOS) is a global company engaged in the production and sale of phosphate-based products, primarily serving the agricultural sector. The company operates in the mining and fertilizer industries, focusing on the development of its projects ...
How the Company Makes Money
Itafos makes money primarily by selling phosphate products into global fertilizer and industrial markets. Its core revenue streams are: (1) Sales of merchant-grade phosphoric acid (MGA), which is sold under offtake arrangements to customers that u...
Itafos Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
74
Positive
Cash Flow
46
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 567.74M | 491.24M | 465.52M | 593.29M | 413.25M |
| Gross Profit | 138.75M | 148.79M | 118.56M | 214.88M | 136.88M |
| EBITDA | 157.80M | 149.25M | 53.75M | 219.59M | 134.33M |
| Net Income | 118.16M | 87.79M | 3.86M | 115.10M | 51.03M |
Balance Sheet | |||||
| Total Assets | 861.76M | 695.86M | 587.23M | 614.01M | 633.85M |
| Cash, Cash Equivalents and Short-Term Investments | 70.36M | 74.37M | 31.05M | 42.81M | 31.57M |
| Total Debt | 112.47M | 108.17M | 103.83M | 143.90M | 254.09M |
| Total Liabilities | 427.52M | 348.03M | 328.50M | 360.89M | 499.25M |
| Stockholders Equity | 434.24M | 347.83M | 258.73M | 252.35M | 133.44M |
Cash Flow | |||||
| Free Cash Flow | 4.69M | 52.57M | 39.96M | 169.37M | 60.42M |
| Operating Cash Flow | 84.19M | 120.05M | 94.72M | 208.37M | 94.50M |
| Investing Cash Flow | -41.29M | -65.20M | -53.33M | -39.00M | -34.08M |
| Financing Cash Flow | -47.71M | -9.37M | -54.23M | -158.32M | -38.43M |
Itafos Technical Analysis
Positive
3.05
Price Trends
3.38
Positive
3.22
Positive
3.08
Positive
Market Momentum
0.08
Positive
54.22
Neutral
79.11
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:IFOS, the sentiment is Positive. The current price of 3.05 is below the 20-day moving average (MA) of 3.81, below the 50-day MA of 3.38, and below the 200-day MA of 3.08, indicating a neutral trend. The MACD of 0.08 indicates Positive momentum. The RSI at 54.22 is Neutral, neither overbought nor oversold. The STOCH value of 79.11 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:IFOS.
Itafos Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | C$730.26M | 3.48 | 30.02% | ― | 20.52% | 1196.33% | |
66 Neutral | C$1.84B | 11.01 | 18.28% | 4.73% | 10.20% | -11.22% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
44 Neutral | C$14.55M | -3.01 | -1497.85% | ― | ― | ― |
* Basic Materials Sector Average
TSE:IFOS
Itafos
3.76
1.63
76.53%
TSE:CHE.UN
Chemtrade Logistics
16.37
8.13
98.59%
TSE:ARGO
Argo Living Soils Corp.
0.64
0.27
72.97%
Itafos Corporate Events
Business Operations and StrategyExecutive/Board Changes
Itafos Grants Equity-Based Awards to Align Leadership With Long-Term Growth
Positive
Mar 26, 2026
Itafos Inc. has granted 477,535 restricted share units and 32,738 deferred share units to its directors and officers as part of its annual compensation program. The awards feature multi-year vesting and performance-based conditions for officers, a...
Business Operations and StrategyDividendsFinancial Disclosures
Itafos Posts Record 2025 Output, Higher Profit Amid Cost Pressures and Strategic Expansion
Positive
Mar 19, 2026
Itafos reported record 2025 production at its Conda and Arraias operations, with full-year revenue rising 14% to $558 million and net income increasing to $116.1 million, even as adjusted EBITDA was flat due to higher sulfur and sulfuric acid cost...
Business Operations and Strategy
Itafos to Court Small-Cap Investors at Sidoti Conference
Positive
Mar 10, 2026
Itafos Inc. will present to investors at the Sidoti Small Cap Conference on March 19, 2026, offering the phosphate and specialty fertilizer producer exposure to a broad small‑ and micro‑cap focused institutional audience. The virtual p...
Business Operations and StrategyFinancial Disclosures
Itafos Sets March Dates for Q4 and 2025 Results and Investor Webcast
Neutral
Mar 5, 2026
Itafos Inc. will release its fourth-quarter 2025 and full-year 2025 financial results after the market close on March 18, 2026, signaling an upcoming update on the performance of its global phosphate and specialty fertilizer operations. Management...
Business Operations and StrategyRegulatory Filings and Compliance
Itafos Files NI 43-101 Report Backing Updated PEA for Brazil’s Arraias Phosphate Project
Positive
Feb 9, 2026
Itafos has filed a National Instrument 43-101 technical report supporting the updated preliminary economic assessment for its Arraias phosphate project in Tocantins, Brazil, formalizing the latest economic and technical work on the operation. Prep...
Business Operations and StrategyFinancial Disclosures
Itafos PEA Backs High-Return Expansion at Brazil’s Arraias Phosphate Project
Positive
Jan 27, 2026
Itafos has completed an updated Preliminary Economic Assessment for its Arraias Phosphate Project in Tocantins, Brazil, confirming a 2 million tonne measured and indicated resource and 3 million tonne inferred resource across four deposits, with h...
Business Operations and StrategyExecutive/Board Changes
Itafos Adds Castlelake Executive to Board as New CLF-Nominated Director
Positive
Jan 17, 2026
Itafos Inc. has appointed Joseph McConnell, a partner and Deputy Co-Chief Investment Officer at Castlelake, L.P., to its Board of Directors effective January 16, 2026, replacing Isaiah Toback as CL Fertilizers Holding LLC’s nominee under an ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.